Internal Medicine, Pulmonary Disease · Rochester, NY
NPI
1558650713
Since 2011
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
601 Elmwood Ave, Box Med
Rochester, NY, 14642
Phone (585) 275-2874
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
169 services
Medicare patients, 2024
51
Average age 71
Drug cost, 2024
$11.0M
1,943 prescriptions
Company payments, 2025
$14K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel J Lachant was code 99214 (office e&m - established), 43 times for 25 patients. In total Daniel J Lachant billed 169 services in 15 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 43 | 25 | $82.18 | $3,534 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 42 | 27 | $12.30 | $516 |
By year: 2022 $13K for 206 services; 2023 $12K for 138 services; 2024 $11K for 169 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel J Lachant prescribed most often to Medicare patients was Tadalafil, with 666 prescriptions and refills. In total Daniel J Lachant wrote 1,943 Medicare prescriptions that cost $11.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tadalafil Generic | 666 | 790 | 84 | $944K |
| Ambrisentan Generic | 516 | 579 | 57 | $2.3M |
| Torsemide Generic | 101 | 174 | 38 | $2,155 |
| Tyvaso Dpi Treprostinil | 97 | 97 | 15 | $2.5M |
| Adempas Riociguat | 89 | 93 | Under 11 | $1.3M |
| Orenitram Er Treprostinil Diolamine | 83 | 84 | Under 11 | $2.2M |
| Spironolactone Generic | 80 | 143 | 31 | $942 |
| Winrevair Sotatercept-Csrk | 68 | 68 | 11 | $1.2M |
| Jardiance Empagliflozin | 40 | 56 | 12 | $32K |
| Metoprolol Succinate Generic | 23 | 29 | Under 11 | $117 |
| Amitriptyline Hcl Generic | 21 | 23 | Under 11 | $134 |
| Prednisone Generic | 18 | 18 | Under 11 | $24.77 |
| Gabapentin Generic | 15 | 23 | Under 11 | $107 |
| Metoprolol Tartrate Generic | 15 | 16 | Under 11 | $23.61 |
| Opsumit Macitentan | 13 | 13 | Under 11 | $164K |
Brand drugs: - claims; generic drugs: 1,511 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel J Lachant $14K ($14K in general payments such as food, travel and fees) from 5 companies. The largest payer was Merck Sharp & Dohme LLC with $7,813.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.